In Vitro Diagnostic Industry in China - POCT XI

1.5 Gestation Category

The most widely used professional and over the counter (OTC) patient self-tests for women’s health are pregnancy and ovulation tests. OTC includes tests offered by pharmacies and other retail outlets. This field of POCT is relatively mature. The demand for pregnancy-related POCT products depends on the number of women with childbearing potential and the number of births. At present, the global population is approximately 8.2 billion, and the global birth rate is approximately 17.13‰, the number of new births worldwide is approximately 132.41 million per year. According to the Kalarama Information, the global POCT pregnancy and childbirth test market generated $962 million in revenue in 2023 and with an increase in revenues of 1.5% will total $1,034 million in 2028. 

Last: In Vitro Diagnostic Industry in China - POCT X

Next: In Vitro Diagnostic Industry in China - POCT XII